logo-loader
LSE:RENE FRA:RQE1

ReNeuron Group PLC

Market:
LSE
Market Cap:
£45.36 m
Price
142.50 GBX
Change
0.00%
52 weeks high
297.50
52 weeks low
71.00

In brief

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.